Data for ST001124   

(Analysis AN001849): Average values per metabolite and experimental factor (Units:pg per 1.5 million cells)

Metabolite structureAll dataF1F2F3F4F5F6F7F8F9F10F11F12F13F14F15F16F17F18F19F20
10(S),17(S)-DiHDoHE (Protectin DX)
- - - - - - - - - - - - - - - - - - - -
11(12)-EET
1.39 1.60 1.37 1.87 1.28 1.22 1.32 1.54 1.41 1.46 1.67 1.20 2.27 1.49 1.42 1.88 2.11 1.29 1.50 1.79
11B-PGF2a
- - - - - - - - - - - - - - - - - - - -
12-HEPE
16.82 16.83 16.67 17.19 17.48 16.71 17.11 16.45 16.74 17.33 18.51 20.90 16.01 16.68 16.57 16.40 15.68 17.18 17.32 16.64
12S-HETE
14.68 15.53 14.88 16.09 14.52 14.19 14.68 14.75 14.89 15.00 14.65 14.52 16.08 14.84 14.30 15.78 14.93 14.90 15.45 15.07
13-HODE
- - - - - - - - - - - - - - - - - - - -
13-OxoODE
- - - - - - - - - - - - - - - - - - - -
14(15)-EET
1.05 1.84 1.18 2.55 1.23 0.86 1.34 1.32 2.54 2.09 1.79 0.84 1.06 1.14 1.33 1.68 0.43 1.46 1.53 1.57
14(S)-HDHA
14.03 14.53 13.64 14.78 14.18 14.28 13.70 13.98 13.85 14.23 13.92 14.25 14.08 14.08 13.89 14.36 13.13 14.00 13.90 13.81
15R-Lipoxin A4 (15R-LXA4)
0.95 0.79 0.66 0.83 0.92 0.86 0.86 0.82 1.11 0.96 0.76 1.44 0.83 0.81 0.80 0.69 0.77 0.96 0.95 0.72
15R-PGF2a
0.50 0.14 0.29 0.56 0.72 1.97 0.35 0.62 0.92 2.45 0.26 0.17 0.33 0.13 0.17 0.15 0.08 0.09 0.09 0.13
15S-HETE
55.57 82.01 63.13 105.88 78.60 68.63 90.93 70.94 130.15 105.33 78.56 65.14 42.79 59.84 67.07 89.06 29.34 67.83 69.43 78.23
17R-Resolvin D1 (17R-RVD1)
- - - - - - - - - - - - - - - - - - - -
17(S)-HDHA
22.71 23.63 21.34 21.99 22.38 22.70 22.47 21.36 21.89 21.35 21.94 23.07 20.54 22.26 21.13 22.35 20.18 20.40 23.67 21.36
18-HEPE
- - - - - - - - - 12.67 - - - - - - - - - -
5S-HETE
6.41 4.89 - 2.80 11.63 1.31 3.32 3.15 7.25 5.35 - 10.74 3.95 7.69 - 6.67 - - 25.61 0.80
6-a-Prostaglandin (PGI2 analog)
- - - - - - - - - - - - - - - - - - - -
7R Maresin-1
- - - - - - - - - - - - - - - - - - - -
7S Maresin-1
- - - - - - - - - - - - - - - - - - - -
8(9)-EET
1.04 1.33 1.22 1.54 1.32 0.89 0.98 1.25 1.17 1.15 0.90 0.84 2.32 1.17 1.05 1.38 1.54 1.18 1.14 1.09
8-iso-15R-PGF2a
0.63 0.86 0.96 0.79 0.71 0.67 0.84 0.96 1.11 0.85 0.83 1.08 0.88 0.79 0.78 0.72 0.68 0.94 1.00 0.85
8-iso-PGF2a
0.99 0.86 0.85 1.15 1.13 1.83 1.12 1.33 1.82 2.50 0.70 0.82 1.20 0.69 0.69 0.86 0.64 0.89 0.72 0.63
8S-HETE
2.65 3.11 2.78 3.21 2.95 2.48 2.75 2.68 3.01 3.16 2.44 2.95 2.50 2.71 2.25 2.67 2.15 2.79 2.94 2.50
9-HODE
- - - - - - - - - - - - - - - - - - - -
9-OxoODE
6.36 5.78 6.56 5.93 5.00 4.64 5.15 6.44 5.28 5.05 6.62 5.03 5.82 6.56 6.45 5.23 4.89 6.83 6.33 6.20
Carbocyclic Thromboxane A2 (TXA2 analog)
1.30 0.93 1.02 1.17 0.94 1.02 0.86 1.27 0.93 1.31 0.99 0.74 1.61 0.94 0.85 1.20 1.05 0.78 1.00 1.09
Lipoxin A4 (LXA4)
0.98 0.79 0.93 1.01 0.99 0.96 0.84 0.78 1.10 1.26 1.02 1.22 1.04 0.74 0.88 0.79 0.78 0.84 1.06 0.89
Lipoxin B4 (LXB4)
0.63 - - - - - - - - - - - - - - - - - - -
LTB4
- 1.86 - - - - - - - - - - 1.94 1.79 1.78 - - 1.84 - -
LTD4_NEG
- - - - - - 1.67 - - - - - - - - - - - - -
LTE4_NEG
- - - - - - - - - - - - - - - - - - - -
PGE2
96.70 14.05 28.59 74.66 113.19 297.51 32.68 54.53 119.44 386.25 12.85 11.82 25.24 11.71 12.80 10.51 7.88 6.02 7.98 11.46
PGF2a
22.35 14.92 18.05 23.38 26.76 51.65 19.00 24.55 30.56 61.14 18.80 15.41 18.80 14.67 15.46 15.22 14.39 14.02 14.40 14.70
Prostaglandin D2
29.80 22.37 23.82 29.05 34.74 71.10 25.37 31.21 35.22 63.86 21.65 24.30 28.37 22.74 21.87 22.33 21.46 22.38 21.90 22.55
Resolvin D1 (RVD1)
0.91 0.87 0.70 0.74 0.73 0.66 0.74 0.94 0.85 0.83 0.78 0.74 0.78 0.72 0.69 1.08 0.62 0.73 0.77 0.91
Resolvin D2 (RVD2)
- - - - - - - - - - - - - - - - - - - -
Resolvin D3 (RVD3)
- - - - - 0.88 1.22 - - - - - - - - - - - - -
Resolvin D5 (RVD5)
0.56 - - - - - - - - - - 0.72 - - - - - - - -
Resolvin E1 (RVE1)
- - - - - - - - - - - - - - - - - - - -
TXB2
- - - - - - - - - - - - - - - - - - - -

Factors:

F1Treatment:2PAHS+p38inhibitor | Time:12
F2Treatment:2PAHS+p38inhibitor | Time:2
F3Treatment:2PAHS+p38inhibitor | Time:24
F4Treatment:2PAHS+p38inhibitor | Time:4
F5Treatment:2PAHS+p38inhibitor | Time:8
F6Treatment:2PAHs | Time:12
F7Treatment:2PAHs | Time:2
F8Treatment:2PAHs | Time:24
F9Treatment:2PAHs | Time:4
F10Treatment:2PAHs | Time:8
F11Treatment:DMSO | Time:12
F12Treatment:DMSO | Time:2
F13Treatment:DMSO | Time:24
F14Treatment:DMSO | Time:4
F15Treatment:DMSO | Time:8
F16Treatment:p38 inhibitor | Time:12
F17Treatment:p38 inhibitor | Time:2
F18Treatment:p38 inhibitor | Time:24
F19Treatment:p38 inhibitor | Time:4
F20Treatment:p38 inhibitor | Time:8
  logo